Binary Co-Cr alloys containing various Cr contents were vacuum induction melted and cast into wedge-shaped copper molds. It was intended to develop a microstructure (1) free from interdendritic segregation and porosity; (2) having minimal intermetallic precipitates; and (3) suitable for biomedical applications. The resultant microstructures were evaluated from sections obtained longitudinally and centrally in the plane normal to the diverging wedge faces. All ingots showed a dendritic microstructure with some characteristic features. For instance, in Co-20–30 wt. % Cr alloys, the chilled cast microstructures consisted of columnar dendrites without interdendritic segregation, a minimum of intermetallic precipitates, and the presence of a predominantly athermal HCP ε-martensite (>80 vol. %). In addition, the metastable FCC γ-Co phase was identified by X-ray diffraction and scanning electron microscopy. In the case of 35–44 wt. % Cr cobalt alloys, a eutectic constituent including the σ-phase were found to develop in the interdendritic regions. From this work, a Co-20 wt. % Cr alloy was chosen for further investigation after heat treating below the γ/ε transition temperature. The resultant tensile strength and ductility were further improved after applying a heat treatment at 730 °C for 30 min, obtaining values of elongation of 26% as compared with 2.55 < 5 of elongation in the as cast condition. Also, the alloy corrosion resistance in artificial saliva was investigated. It was found that the exhibited corrosion rates for the as-cast and heat-treated conditions are between those reported for other similar systems.

In recent years, increasing interest has been placed in the development of Zn alloys for absorbable biomedical applications. It has been demonstrated that these alloys are potential candidates for endovascular applications. In the present work, a novel Zn-12.5Ag-1Mg alloy was investigated as a potential biomedical absorbable material. As a reference, the exhibited biocompatible properties are compared with those of pure Zn and a Zn-1Mg alloy. All the alloys investigated in this work were cast in a water-cooled Cu-mold (chill casting). Subsequently, the alloys were solution-treated and then extruded. The microstructural evolution at each stage of the alloy processing was resolved by analytical means including optical, scanning, transmission microscopy, and X-ray diffraction. By these means, the various phases belonging to this alloy system were disclosed. In addition, determinations of both corrosion and mechanical properties were carried out in the proposed Zn-12.5Ag-1Mg alloy. In particular, an excellent combination of strength and ductility was found, which is attributed to grain refinement as well as the precipitation of a uniform distribution of refined phases (i.e., AgZn solid solution, ε-AgZn₃, and Ag_0.15MgZn_1.85 intermetallics). All the precipitated intermetallics were embedded in a η-Zn matrix. As for the corrosion degradation in the physiological NaCl solution in the as-extruded condition, the experimental outcome indicates that the Zn-12.5Ag-1Mg alloy exhibits degradation rates far superior to currently reported ones for Zn-based alloys intended for absorbable biomedical applications.